pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Chronic Illness in 2 studies
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, H | 1 |
| Meguro, T | 1 |
| Badr, A | 1 |
| Zhang, JH | 1 |
| McCleskey, EW | 1 |
2 other studies available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Chronic Illness
| Article | Year |
|---|---|
Suramin-induced reversal of chronic cerebral vasospasm in experimental subarachnoid hemorrhage.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Chronic Disease; Dogs; Female; Male; Oxyhemo | 2002 |
Neurobiology: new player in pain.
Topics: Animals; Chronic Disease; Microglia; Pain; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; | 2003 |